SYBX (Synlogic) Earnings per share for the last four quarters

Synlogic Corp (SYBX) - corporate logo

Synlogic, Inc. (SYBX) is monetizing an innovative synthetic biotic system, establishing a foundation for licensing payments. However, historical YoY EPS growth over the last 12 months shows a sharp decline: the macro-resilience of therapies for congenital metabolic pathologies did not save the asset from restructuring and liquidation. The business is currently burdened by costs associated with settling obligations, and the indicator value reaches 93.60.

SYBX synlogictx.com Net earnings per share (EPS TTM) (02/11/2024 - 01/24/2026)

SYBX (synlogictx.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Price Synlogic Inc.|SYBX - Consensus Target
- business market valuation indicators:
Market Value Synlogic Corp|SYBX - Enterprise Value
- business book valuation details:
Book Value per Share Synlogic|SYBX - Book Capitalization|Market Value to Book Value Ratio synlogictx.com|SYBX - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Capital Synlogic, Inc.|SYBX - Long-Term Debt to Equity|Short-Term Debt to Equity synlogictx.com|SYBX - Company Aggregate Debts|Debts to Net Assets Synlogic, Inc.|SYBX - Company Long-Term Debt|Short-Term Debt Volume Synlogic|Quick Liquidity Indicator synlogictx.com
- earnings and multiples data:
SYBX - Company Net Income|Company Profit Forecast Synlogic, Inc.|SYBX - Price to Earnings Ratio|Projected Price to Earnings Ratio Synlogic|SYBX - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Synlogic, Inc.|SYBX - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Synlogic|SYBX - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months synlogictx.com|SYBX - Earnings growth in current year|Net earnings per one share growth forecast for next year Synlogic, Inc.
- sales and revenue indicators:
SYBX - Revenue and Sales Volume|Company Future Sales synlogictx.com|SYBX - P/S Multiple|Forward Price-to-Revenue Multiple Synlogic|SYBX - Revenue Growth YoY (Last 12 Months)
Fundamental company valuation:SYBX (Synlogic Corp)
Core merchandise of Synlogic, Inc.

Year-over-year EPS growth (TTM) measures the net profit per share dynamics over twelve months, allowing for an assessment of value generation efficiency relative to the previous period. By analyzing the history of year-over-year EPS (TTM) changes, an investor can see the impact of laboratory robotization at Synlogic, Inc. (SYBX) on profitability, where the automation of dosing and data validation should translate into cost reductions and an increase in per-unit income.

Competitor analysis

Net earnings per one share for the last twelve months Ascendis Pharma Inc.|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Therapeutics|Net earnings per share (EPS TTM) MTSR|Earnings per share for the last twelve months MLTX (MoonLake Immunotherapeutics AG)|Earnings per share for the last twelve months crinetics.com CRNX|NewAmsterdam Pharma Corp (NAMS) - Net earnings per one share for the last twelve months|SLNO - Earnings per share for the last twelve months|FOLD: Earnings per share for the last twelve months|ETNB: Net earnings per share (EPS TTM)|AGIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Structure Corp|MiMedx Corp (MDXG) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months rezolutebio.com (RZLT)|Net earnings per share for the last 12 months lexpharma.com LXRX|Net earnings per share (EPS TTM) MBX (MBX Biosciences)|Altimmune Corp - Earnings per share for the last twelve months|Aardvark Therapeutics Inc. - Net earnings per share (EPS TTM)|SGMT - Net earnings per share (EPS TTM)|BioAge Labs (BIOA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months biomeafusion.com (BMEA)|Earnings per share for the last twelve months Quince Therapeutics, Inc.|Net earnings per share for the last 12 months Fractyl (GUTS)|Net earnings per share for the last 12 months VTVT (vTv Therapeutics Inc.)|ATPC - Net earnings per one share for the last twelve months|Pluri Inc. - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters lipocine.com (LPCN)|MTNB - Earnings per share for the last twelve months|Earnings per share for the trailing year SPRB (Spruce Biosciences)|GLTO (Galecto Corp) - Net earnings per share for the last 12 months|Carmell Corp - Earnings per share for the trailing year|LUMO (Lumos Therapeutics) - Net earnings per share (EPS TTM)|ONVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) RDUS